There is a need for safe and effective platform vaccines to protect against coronavirus
disease 2019 (COVID-19) and other infectious diseases. In this randomized, double …

In a recent study of our group with the acronym ACTIVATE, Bacillus Calmete-Guérin (BCG)
vaccination reduced the occurrence of new infections compared to placebo vaccination in …

Abstract Background The bacille Calmette–Guérin (BCG) vaccine has immunomodulatory
“off-target” effects that have been hypothesized to protect against coronavirus disease 2019 …

Introduction Universal coverage of vaccines alone cannot be relied upon to protect at-risk
populations in lower-and middle-income countries against the impact of the coronavirus …

A number of coronavirus disease 2019 (COVID-19) vaccine candidates have shown
promising results, but substantial uncertainty remains regarding their effectiveness and …

The ongoing severe acute respiratory sickness coronavirus 2 (SARS‐CoV‐2) pandemic has
resulted in more than 3,600,000 detected cases of COVID‐19 illness and nearly 260,000 …

Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, and there is
limited data on effective therapies. Bacillus Calmette–Guérin (BCG) vaccine, a live …

Abstract The Bacillus Calmette–Guerin (BCG) vaccine provides protection against
tuberculosis (TB), and is thought to provide protection against non-TB infectious diseases …

The evidence that BCG (bacille Calmette-Guerin) vaccine may increase the ability of the
immune system to fight off pathogens other than tuberculosis has been studied in the past …

Despite of the rapid development of the vaccines against the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), it will take several months to have enough doses …